Huperzine A
Food supplement declared in France, decision dated 22 February 2026
Huperzine A (Apollo's Hegemony) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Apollo's Hegemony
- Food business operator placing the product on the market
- MZ-Store S.A.
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 1 gélule par jour
- Directions for use
- Prendre 1 gélule par jour avec un verre d’eau, de préférence au cours d’un repas.
- Intended populations
- Hommes et femmes de 18 ans et plus
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Problèmes cardiaques, Sous antidépresseurs, Sous traitement médicamenteux
- Objectives stated by the manufacturer (these are not authorised claims)
- Système nerveux
Declaration 357710, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Huperzia serrata (Thunb.) Rothm. | Parties aériennes | Extrait sec hydroalcoolique | 20 mg |
Additives
E551, E470b, E460, E464
Other ingredients
maltodextrine, amidon de riz
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé aux femmes enceintes ou allaitantes et aux personnes de moins de 18 ans. Déconseillé en cas de troubles cardiaques. En cas de traitement médicamenteux (notamment agissant sur le système cholinergique), demander l’avis d’un professionnel de santé. Ne pas dépasser la dose journalière recommandée.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Huperzine A Nutrixeal, declared in 2026 : different composition: 2 ingredient(s) added, 6 missing
- Huperzine-A SN Worlwide Unipessoal LDA, declared in 2024 : different composition: 1 ingredient(s) added, 6 missing
- huperzine A VATIS, declared in 2023 : different composition: 1 ingredient(s) added, 5 missing
- Huperzine A Tulip BioPharma, declared in 2022 : different composition: 1 ingredient(s) added, 6 missing
- Huperzine A DG Supplements, declared in 2022 : different composition: 0 ingredient(s) added, 4 missing
- HUPERZINE A Anjou Développement Nutrition, declared in 2019 : different composition: 6 ingredient(s) added, 5 missing
- Huperzine A Nutrixeal, declared in 2018 : different composition: 2 ingredient(s) added, 6 missing
- huperzine A HELIO VALERDI, declared in 2023, withdrawn from the market : different composition: 1 ingredient(s) added, 5 missing
Brand : Apollo's Hegemony